博落回提取物白屈菜紅碱
品名:Macleaya cordata Extrat
拉丁名: Macleaya cordata (Willd.)R.Br.
有效成份:Total alkaloids,sanguinarine,chelerythrine.
外觀:orange red fine powder
規格:Total alkaloids: 20%-60%;
Ratio product: 5:1, 10:1,20:1 TLC
sanguinarine 1-30%,chelerythrine:1-50%
檢測方式:HPLC / TLC
博落回及博落回提取物在獸藥中應用
獸用博落回清熱解毒消腫、抗菌抗病毒消炎效果好，是一種 綠色獸藥產品。具有清熱解毒消腫、抗菌抗病毒消炎功效，用於治療各種家畜流行性感冒、上呼吸道感染、肺炎、豬肺疫、消化道感染、傳染性胃腸炎、腹瀉痢疾、仔豬白痢、黃痢、高熱性疾病、病毒感染、禽霍亂、雞白痢等。
飼料添加劑-促生長作用
博落回提取物的主要成分血根碱具有抑制膽碱脂酶活性，刺激唾液分泌，並具有利尿、外周抗腎上腺素解交感作用(Federico Bianco等，2006)。博落回及博落回提取物在獸藥中應用 同時具有能抑制芳香族氨基酸脫羧酶的作用，Drata等(1996)認為，血根碱通過這一作用調節色氨酸-5-羥色胺代謝途徑，而增加飼養動物的采食量。而Lenfeld等(1981)研究認為，博落回中含有的QBA的這兩種作用的結合是它提高動物生長性能的原因。QBA可能通過與腸道接觸而發揮抗菌和抗炎的作用，從而降低斷奶仔豬腹瀉率、保障腸道健康，可能是提高動物生產性能的主要原因。
血根碱係為中華人民共和國農業部公告第318號中公佈的飼料添加劑品種。
博落回提取物總碱1-60%
以上資料 由長沙上禾生物整理 產品詳詢13657416805
References參考文獻:
- 1.
Lilley DMJ (1995) Proc Natl Acad Sci USA 92:7140–7142
- 2.
Hermann T, Patel DJ (2000) Structure 8:R47–R54
- 3.
Xi Z, Hwang GS, Goldberg IH, Harris JL, Pennington WT, Fouad FS, Qabaja G, Wright JM, Jones GB (2002) Chem Biol 9:925–931
- 4.
Nakatani K, Horie S, Murase T, Hagihara S, Saito I (2003) Bioorg Med Chem 11:2347–2353
- 5.
Nakatani K, Sando S, Saito I (2000) J Am Chem Soc 122:2172–2177
- 6.
Xi Z, Goldberg IH (2002) Enediyne antibiotic neocarzinostatin as a radical-based probe of bulged structures in nucleic acids. In: Jones GB, Chapman BJ (eds) Advances in DNA sequence-specific agents. Elsevier, Amsterdam, Netherlands
- 7.
Malkov VA, Biswas I, Camerini-Otero D, Hsieh P (1997) J Biol Chem 272:23811–23817
- 8.
Wang YH, Bortner CD, Griffith J (1993) J Biol Chem 268:17571–17577
- 9.
Lilley DMS (1995) Proc Natl Acad Sci USA 92:7140–7142
- 10.
Dingwall C, Ernberg I, Gait MJ, Gree SM, Heaphy S, Karn J, Lowe AD, Singh M, Skinner MA, Valerio R (1989) Proc Natl Acad Sci USA 86:6925–6929
- 11.
Greenblatt J, Nodwell JR, Mason SW (1993) Nature 364:401–406
- 12.
Wells RD (1996) J Biol Chem 27:2875–2878
- 13.
Perutz MF (1996) Curr Opin Struct Biol 6:848–858
- 14.
Kunkel TA (1993) Nature 365:207–209
- 15.
Harvey SC (1997) Biochemistry 36:3047–3049
- 16.
Kappen LS, Xi Z, Jones GB, Goldberg IH (2003) Biochemistry 42:2166–2173
- 17.
Ashley CT, Warren ST (1995) Annu Rev Genetics 29:703–728
- 18.
Adhami VM, Aziz MH, Reagan-Shaw SR (2004) Mol Cancer Ther 3:933–940
- 19.
Ahmad N, Gupta S, Husain MM, Heiskanen KM, Mukhtar H (2000) Clin Cancer Res 6:1524–1528
- 20.
Chmura SJ, Dolan ME, Cha A, Mauceri HJ, Kufe DW, Ralph R (2000) Clin Cancer Res 6:737–742
- 21.
Bai LP, Zhao ZZ, Cai Z, Jiang ZH (2006) Bioorg Med Chem 14:5439–544
- 22.
Xi Z, Zhang R, Yu Z, Ouyang D, Huang R (2005) Bioorg Med Chem Lett 15:2673–2677
- 23.
Bai LP, Zhao ZZ, Cai Z, Jiang ZH (2006) Nucleic Acids Symp Ser 50:197–198
- 24.
Schneider HJ, Yatsimirsky AK (2000) Principles and methods in supramolecular chemistry. Wiley, New York
- 25.
Wan KX, Shibue T, Gross M (2000) J Am Chem Soc 122:300–307
- 26.
Chen WH, Chan CL, Cai Z, Luo GA, Jiang ZH (2004) Bioorg Med Chem Lett 14:4955–4959
- 27.
Moody EM, Bevilacqua PC (2004) J Am Chem Soc 126:9570–9577
- 28.
Qin Y, Pang JY, Chen WH, Cai Z, Jiang ZH (2006) Bioorg Med Chem 14:25–32
- 29.
Long YH, Bai LP, Qin Y, Pang JY, Chen WH, Cai Z, Xu ZL, Jiang ZH (2006) Bioorg Med Chem 14:4670–4676
- 30.
Senior MM, Jones RA, Breslauer KJ (1988) Proc Natl Acad Sci USA 85:6242–6246
- 31.
Rosu F, Pirotte S, De Pauw E, Gabelica V (2006) Int J Mass Spectrum 253:156–171
- 32.
Carrasco C, Rosu F, Gabelica V, Houssier C, De Pauw E, Garbay-Jaureguiberry C, Roques B, Wilson WD, Chaires JB, Waring MJ, Bailly C (2002) ChemBioChem 3:1235–1241
- 33.
Rosu F, De Pauw E, Guittat L, Alberti P, Lacroix L, Mailliet P, Riou JF, Mergny JL (2003) Biochemistry 42:10361–10371
- 34.
Jones GB, Lin Y, Xiao Z, Kappen L, Goldberg IH (2007) Bioorg Med Chem 15:784–790
- 35.
Xi Z, Zhang R, Yu Z, Ouyang D (2006) Bioorg Med Chem Lett 16:4300–4304